New registry to monitor safety of LOBO device in bleeding emergencies
NCT ID NCT07525518
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry will follow 500 adults who receive the LOBO Vascular Occlusion System, a device used to block blood vessels in cases of arterial bleeding or other conditions. The goal is to see how safe and effective the device is in everyday medical practice. Participants are enrolled after treatment, and the study will track device-related complications and how well the device stops bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LOBO Vascular Occlusion System (a device used to block blood vessels)
What this could lead to
If successful, this registry will provide real-world data on how well the LOBO device works and its safety, helping doctors make better treatment decisions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be limited by patient selection and lack of a comparison group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMBOLIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UMASS Chan Medical School
Worcester, Massachusetts, 01655, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States